135 related articles for article (PubMed ID: 1361164)
1. FDA approves treatment IND protocol for taxol.
Clin Pharm; 1992 Nov; 11(11):912. PubMed ID: 1361164
[No Abstract] [Full Text] [Related]
2. FDA approves AIDS drug.
Am Pharm; 1992 Sep; NS32(9):13-4. PubMed ID: 1332462
[No Abstract] [Full Text] [Related]
3. TransMolecular receives FDA approval for 131-I-TM-601 IND application.
Expert Rev Anticancer Ther; 2002 Apr; 2(2):139. PubMed ID: 12113233
[No Abstract] [Full Text] [Related]
4. NICE approves Taxol for ovarian cancer.
Kmietowicz Z
BMJ; 2000 May; 320(7245):1293. PubMed ID: 10807610
[No Abstract] [Full Text] [Related]
5. FDA advisors recommend approval of taxol for node-positive breast cancer.
Oncologist; 1999; 4(5):430-1. PubMed ID: 10551561
[No Abstract] [Full Text] [Related]
6. Expanded access to investigational drugs for treatment use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Aug; 74(155):40900-45. PubMed ID: 19691173
[TBL] [Abstract][Full Text] [Related]
7. New drug awaiting FDA approval may reverse bone loss.
Mayo Clin Health Lett; 2001 Nov; 19(11):4. PubMed ID: 11692627
[No Abstract] [Full Text] [Related]
8. Charging for investigational drugs under an investigational new drug application. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Aug; 74(155):40871-900. PubMed ID: 19691172
[TBL] [Abstract][Full Text] [Related]
9. Expanded clinical trials of treatments for multiple sclerosis: copolymer 1 (COP-1) treatment investigational new drug (IND) program.
Stark Y
Ann Neurol; 1994 Jul; 36(1):114-5. PubMed ID: 8024251
[No Abstract] [Full Text] [Related]
10. Regulatory watch: FDA guidance on co-developing investigational drugs.
Nat Rev Drug Discov; 2011 Feb; 10(2):86. PubMed ID: 21283094
[No Abstract] [Full Text] [Related]
11. Current good manufacturing practice and investigational new drugs intended for use in clinical trials. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Jul; 73(136):40453-63. PubMed ID: 18850678
[TBL] [Abstract][Full Text] [Related]
12. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency.
Schultheis LW; Rappaport BA
Anesth Analg; 2007 Mar; 104(3):479-80. PubMed ID: 17312189
[No Abstract] [Full Text] [Related]
13. Patient group seeks overhaul of FDA clinical trial system in court.
Hede K
J Natl Cancer Inst; 2006 Sep; 98(18):1268-70. PubMed ID: 16985242
[No Abstract] [Full Text] [Related]
14. Investigational new drug applications; clinical holds--FDA. Direct final rule.
Fed Regist; 1998 Dec; 63(239):68676-8. PubMed ID: 10187558
[TBL] [Abstract][Full Text] [Related]
15. Can single-patient investigational new drug studies hurry slow trains to the fast track?
Chenoweth D
Drug Discov Today; 2006 Mar; 11(5-6):185-6. PubMed ID: 16580594
[TBL] [Abstract][Full Text] [Related]
16. FDA approves splice-modulating drug.
Mullard A
Nat Rev Drug Discov; 2017 Feb; 16(2):77. PubMed ID: 28148945
[No Abstract] [Full Text] [Related]
17. Investigational new drug application; exception from informed consent; technical amendment--FDA. Final rule.
Fed Regist; 1997 Jun; 62(115):32479. PubMed ID: 10169828
[TBL] [Abstract][Full Text] [Related]
18. FDA finds new ways to speed treatment to patients.
Flieger K
FDA Consum; 1993 Oct; 27(8):14-8. PubMed ID: 10129048
[No Abstract] [Full Text] [Related]
19. Investigational drugs and research.
Tueting P
Psychiatr Med; 1991; 9(2):333-47. PubMed ID: 1857767
[TBL] [Abstract][Full Text] [Related]
20. New, expanded, and modified use of approved antineoplastic agents in ovarian cancer.
Markman M
Oncologist; 2007 Feb; 12(2):186-90. PubMed ID: 17296814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
